Updated on 3 August 2026
Pharmacokinetic Analysis for Clinical Trials
Executive Assistant ǀ Client Manager ǀ Medical Writer at M.A.R.C.O. GmbH & Co. KG - Institute for Clinical Research and Statistics
Düsseldorf, Germany
About
At M.A.R.C.O. we have a specialized Pharmacokinetics team providing following services:
-
Development / review of PK/PD analysis plans
-
Calculation of PK parameters (non-compartmental)
-
PK / PD modeling / simulation
-
Modeling and simulation strategies to optimize drug development
-
Superposition
-
Population PK approaches and exposure/response to support dose finding
-
Software: Phoenix® WinNonLin®, NLME®
Our PK/PD services have been applied to more than 250 studies including:
-
First-in-men / single and multiple dose ascending
-
Bioequivalence
-
Drug-drug interaction, food-drug interaction
-
Antibodies
-
Human mass balance
-
Drug inhalation
-
Hormones
-
Ethnical differences
Organisation
Similar opportunities
Project cooperation
- Franchise
- Strategic Partner
- Technological contribution
- Market Access Contribution
- Early prototype / no customers
- Finding Partners - Completing consortia
Kenichiro Hirano
Director of Daiwa Special Glass at Daiwa Special Glass
Osaka, Japan
Product
- Buyer
- Suppliers
- VALUE CHAIN
- LIFE SCIENCE
- BIOLOGY / BIOTECHNOLOGY
- INDUSTRIAL BIOTECHNOLOGY
- MICRO- AND NANOTECHNOLOGY
Kenichiro Hirano
Director of Daiwa Special Glass at Daiwa Special Glass
Osaka, Japan
Partnership
- Research
- Business
- Franchising
- Joint development
- Testing of technology
Kenichiro Hirano
Director of Daiwa Special Glass at Daiwa Special Glass
Osaka, Japan